Method for treating chronic prostatitis

FIELD: medicine, andrology.

SUBSTANCE: boiling velvet antlers water should be applied in the form of aerosol onto "panties" area of patient's body surface in combination with dry heat thrice every other day, about 8-10 procedures/course. The innovation enables to minimize the load upon cardio-vascular system and enhance surface circulation.

EFFECT: higher efficiency of therapy.

1 ex

 

The invention relates to medicine, namely to andrology, and can be used in the treatment of chronic prostatitis.

Treatment of chronic prostatitis, a fairly common disease polietiologic nature, is a big problem for andrology.

Chronic prostatitis - chronic disease that is characterized by a prolonged course, sexual function disorders and low efficiency of the treatment.

In recent years, increasingly for the treatment of chronic prostatitis using products of reindeer antlers (pantogematogen and antler cooking water).

There is a method of treatment of chronic prostatitis using shared baths antler cooking water, which has anti-inflammatory, trophic, adaptogenic and biostimulating effect, helps to regulate the endocrine glands, maintains and improves sexual function. Take a bath temperature of 36-37°With, for 8-10 minutes daily or every other day, on the course of 8-10 treatments.

The disadvantages of this method are:

- a significant load on the cardiovascular (SS) and the nervous system (NS);

- a great probability of pathological baldereschi;

- the need for special equipment;

- the high cost of treatment;

On the closer achieved by the positive effect is a method of treatment of chronic prostatitis with the use of wet wraps, namely, that after warming up in the sauna (2 sunset 5-7 min) patient tightly wrap sheets soaked antler cooking water, and laid on the couch. The duration of the procedure from 15 to 40 min on a course of 6-12 treatments.

Disadvantages: possible psychological intolerance of the procedure, the load on the cardiovascular system and the high cost of treatment.

The authors propose an effective method for the treatment of chronic prostatitis by the combined effect of antler aerosol cooking water and dry heat using a dry-heat chamber at trusilova area of the body surface.

A positive result of the proposed method is the reduction of pathological reactions and the reduction of treatment time.

A positive result is achieved by the impact of the antler of the cooking water on the preheated surface of the body, which is instrumental in opening the skin pores and strengthen the near-surface circulation, resulting in increased absorption capacity of the skin surface, the load on the cardiovascular system and the likelihood of pathological reactions are minimized, since the effects of temperature carried out in short periods.

The method is as follows.

For the preparation of antler cooking water use 50 g to servirovanyj antlers (LLC Kurdum") in 5 liters of water, heating on a water bath, bring three sessions of 5 min to a temperature of 92-96°intermittently for 20 min between sessions. Prepared antler cooking water is used in the form of an aerosol, where the medium is air, and the dispersed phase particle antler cooking water.

When the dispersion is the increase in total suspended solids cooking water compared to the original, provides maximum surface contact of the cooking water, increases its biological activity due to a small electrical charge, resulting dispersion, accelerates the absorption and flow of biologically active substances through the blood to the tissues.

After hygienic soul (2-5 min) is given by 3 successive cycles of exposure to dry heat using a dry-heat chamber for a total duration of 5-7 minutes at a temperature of 80-90°With relative humidity of 15-20%. Handling manual vaporizer skin "trusikovuyu" zone of the patient is made antler broth for 1 minute.

After the procedure the patient is served sheets for 20-30 minutes Procedure is carried out through the day, the course of 8-10 treatments.

Clinical example.

Patient M 49 years have complained of constant aching pain in the suprapubic area, perineum, reduced sexual function and orgasm of wear. From the anamnesis diseases the project: suffering from chronic prostatitis for about 15 years each year passed, conservative therapy with the duration of the effect after each exacerbation of not more than 2 months, with a gradual return of the pain syndrome and sexual dysfunction. Of comorbidity, it is important to highlight cardiovascular pathology, namely coronary heart disease and symptomatic hypertension. Given the duration of the underlying disease, relapsing course with frequent relapses, and decided to add to the standard therapy of acute exacerbation of chronic prostatitis coarse election dispersion antler cooking water "trusilova" zone in combination with a dry-heat exposure. On the background of complex therapy, the patient reported good tolerability carried out additional techniques, as well as the relief of pain in the suprapubic area and perineum for 3 days, increase sexual function in 8 day of therapy and full recovery after 15 days. During follow-up after 3, 6, 12 months, the patient was noted persistent remission (absence of pain) and the normalization of sexual life.

The inventive method has a high efficiency and selectivity, no significant burden on SSA, does not require expensive special. equipment that can significantly reduce the cost of procedures in the treatment of hronicheskoj the prostatitis.

The method of treatment of chronic prostatitis by a combined use of antler cooking water and heat, characterized in that the antler cooking water is used aerosol, "trusilova" area of the body surface of the patient in combination with a dry heat, 3 times a day, 8-10 procedures for the course.



 

Same patents:

FIELD: medicine, endocrinology, pharmacy.

SUBSTANCE: invention relates to a pharmaceutical composition comprising drospirenone as the first active agent in the amount corresponding to daily dose from 2 to 4 mg in administration of the composition, and ethynylestradiol as the second active agent in the amount corresponding to daily dose from 0.01 to 0.05 mg in combination with one or some pharmaceutically acceptable vehicles or additives. Drospirenone as a component of the pharmaceutical composition is in the finely divided form. The preparation comprises some separately packages and individually taken medicinal units placed in the unit package and designated for oral administration for at least 21 days at a time and indicated daily medicinal units comprise the combination of drospirenone and ethynylestradiol. The preparation can comprise 7 and less daily doses no containing any active agent or containing ethynylestradiol only. The combination of ethynylestradiol and drospirenone provides the safety contraceptive activity due to using the maximal dose of drospirenone being without adverse effects, in particular, excessive diuresis.

EFFECT: improved and valuable properties of combination.

34 cl, 5 dwg, 5 ex

FIELD: medicine, endocrinology, pharmacy.

SUBSTANCE: invention relates to a pharmaceutical composition comprising drospirenone as the first active agent in the amount corresponding to daily dose from 2 to 4 mg in administration of the composition, and ethynylestradiol as the second active agent in the amount corresponding to daily dose from 0.01 to 0.05 mg in combination with one or some pharmaceutically acceptable vehicles or additives. Drospirenone as a component of the pharmaceutical composition is in the finely divided form. The preparation comprises some separately packages and individually taken medicinal units placed in the unit package and designated for oral administration for at least 21 days at a time and indicated daily medicinal units comprise the combination of drospirenone and ethynylestradiol. The preparation can comprise 7 and less daily doses no containing any active agent or containing ethynylestradiol only. The combination of ethynylestradiol and drospirenone provides the safety contraceptive activity due to using the maximal dose of drospirenone being without adverse effects, in particular, excessive diuresis.

EFFECT: improved and valuable properties of combination.

34 cl, 5 dwg, 5 ex

FIELD: medicine, obstetrics.

SUBSTANCE: one should conduct antibacterial therapy 3 mo before planned pregnancy consisting of preparations of tetracyclinic group or macrolides in combination with nystatin and metronidasol to continue it since the first day of menstrual cycle and, also, it is necessary to perform correction of vaginal biocenosis, and about 3-4 wk after therapy carried out for 2 next mo before planned pregnancy starting, also, since the first day of menstrual cycle - metabolic therapy; At the onset of pregnancy one should conduct courses for preventing placental deficiency dealing with introduction of preparations that improve uterine-placental circulation, and preparations that improve rheological properties of blood and vitamin-metabolic therapy or the same preparations, and additionally - introduction of macrolides ad viferon rectally in case of activation of chlamydial infection. The present innovation enables to sanitize uterine cavity, improve uterine-placental circulation, restoration of placental tissue structure that, in its turn favors the birth of healthy generation.

EFFECT: higher efficiency of prophylaxis.

1 cl, 9 tbl

FIELD: veterinary pharmacology.

SUBSTANCE: The suggested method deals with interaction of valerianic acid anhydride with steroid alcohol - 17α-acetoxy-3β-hydroxy-6-methylpregna-4.6-dien-20-on at molar ratio being 1.1-1.5:1 to steroid, which should be implemented in pyridine medium in volume-weight ratio of 1.5-2.0:1 pyridine to steroid at 22-25°C, excess of anhydride should be hydrolyzed with water at the quantity of 15-20% against the volume of reaction mass, as for developed valerianic acid, it should be dissolved in 1-1.5%-ammonia aqueous solution and a target product should be filtered, washed with water up to neutral reaction to be washed with methanol. The innovation provides obtaining new target product of higher purification degree.

EFFECT: higher efficiency.

7 ex, 7 tbl

FIELD: medicine, obstetrics, gynecology.

SUBSTANCE: one should intravenously inject Reamberin 1.5% up to 400 ml solution daily, percutaneously affect with magneto-infrared laser, wave length being 0.89 mcm, impulse power of infrared radiation corresponds to 4 W. One should affect uterine and adnexal area alternatively, at exposure being about 2-3 min for every region, radiation frequency being 5 Hz and 50 Hz altered every other day. Since the second day of therapy one should additionally supply laser light flow directly towards uterine area through vaginal arch for 1 min at frequency of 1000 Hz. Total course of therapy corresponds to about 5-7 d. The innovation enables to increase immunological body strength, decrease relapse frequency and decrease side effects of curative preparations applied.

EFFECT: higher efficiency of therapy.

2 ex, 1 tbl

FIELD: medicine.

SUBSTANCE: method involves introducing 0.06% sodium hypochlorite solution from intravaginally arranged cathode during 10-15 min every session in 5-7 days long course.

EFFECT: reduced risk of abdominal pregnancy relapses; retained reproductive function.

1 tbl

FIELD: medicine, obstetrics.

SUBSTANCE: the present innovation deals with introducing the complex of medicinal preparations directed for treating different complications during pregnancy. Moreover, along with applying the above-mentioned complex it is necessary to introduce actovegin as uterotonic remedy per 2 tablets thrice daily. The innovation enables to normalize myometrium state and that of uterine-placental circulation at efficiency being 93%.

EFFECT: higher efficiency.

2 ex

FIELD: medicine, gynecology, surgery.

SUBSTANCE: one should introduce 3.5%-chitosan ascorbate gel into fistulous channel that contains metronidasol at the dosage of 2 mg/ml, at the volume up to 20 ml once/2 d till complete fistula's closing. The present innovation enables to activate reparative processes and fistulous epithelization that favors for closing fistulous channel in earlier terms.

EFFECT: higher efficiency of therapy conducted.

2 ex

FIELD: medicine, gynecology.

SUBSTANCE: the present innovation deals with treating vaginal dryness and reproductive dysfunction in women either during or after menopause. For this purpose, it is necessary to introduce (deaminohydroxy)thoremifen or its salts or ethers at dosage ranged 25-100 mg daily either perorally or transdermally. The innovation provides efficient therapy at resistance to other types of hormonal therapy, due to multi-component impact upon disease pathogenesis.

EFFECT: higher efficiency of therapy.

8 cl, 2 dwg, 1 tbl

FIELD: veterinary science.

SUBSTANCE: one should intravenously inject for a cow 150 ml 40%-glucose solution simultaneously with 100 ml 10%-calcium chloride solution 1 h after fetal birth, and oxytocin intramuscularly at the dosage of 6 U/100 kg body weight and magestrophan intramuscularly at the dosage of 2 ml, in 3 h one should introduce oxytocin intramuscularly at the same dosage. The suggested method is efficient in preventing puerperal uterine subinvolution in cows that enables to shorten sterility duration and coefficient of insemination.

EFFECT: higher efficiency of prophylaxis.

2 ex, 2 tbl

FIELD: surgical facilities.

SUBSTANCE: invention provides material suitable as hemostatic and wound-healing remedy in low-invasive internal surgery involving endoscopic techniques. Allogenic connective-tissue formations (tendons, fascias, dermis) are subjected to mechanical cleaning to remove the rests of adjoining tissues and foreign bodies, washed with running water during 5-10 min, degreased by cold (+4оС) acetone, placed for 5-10 min in 3% hydrogen peroxide solution to remove blood, and thrice rinsed with 0.9% sodium chloride solution. Treated tissues are frozen in cryogenic chamber at -45оС and dried in vacuo to constant weight using liophilic drying technique. Dried material is then wetted at 1:5 weight ratio in solution containing calculated quantities of hemostatic (fibrinogen), fibrinolysis inhibitor (aminocapronic acid), and antibiotic (cephalexin) for 10-20 min until biomaterial structure is completely and uniformly impregnated. Solution id prepared at +4оС by consecutively dissolving 0.2 g cephalexin and 1 g fibrinogen in 10 ml of 5% aminocapronic acid solution. Thereafter, biomaterial is once again frozen and subjected to liophilic drying, then ground on blade-type mill (e.g. "Cyclotec", Foss Tecator) to particle size 0.1-0.25 mm, which are packaged by 0.5 g doses into glass 20-ml bottles, tightly sealed, and sterilized by gamma radiation in dose 2.5 MRad (25 kGr).

EFFECT: simplified technology, improved quality and structure of material.

The invention relates to medical and cosmetic industry
The invention relates to medicine, in particular to methods for biological coatings for wound closure in the treatment of patients with burns and mechanical damage to the skin

The invention relates to medicine, namely to the stimulants of colony-forming cells
The invention relates to medicine, in particular for experimental medicine
The invention relates to medicine, namely to experimental medicine and surgery
The invention relates to medicine, urology, Pediatrics
The invention relates to medicine and relates to the production of purified activated factor X clotting

The invention relates to medicine and biology, more specifically a process for the production of collagen, and can be used in the treatment of various tissue pathologies, for cell cultivation

FIELD: medical engineering.

SUBSTANCE: device has horizontally arranged cylindrical metal reservoir having external heat-insulating coating, couch introducible into the reservoir along horizontal symmetry plane and exhaust pipe with shutter and air-heating system. The reservoir is of 600 mm large diameter, 700-800 mm in length and single bottom. The reservoir has two cylindrical rest wood members arranged in parallel to each other and having 50-60 mm large diameter for placing patient feet. The couch enters the reservoir 50-100 mm deep and is fixed with its edge on supporting reservoir rod in parallel to the rest members and with its second rest on feet placed 250-400 mm far from the second couch end. Conical hose is fastened with attachment clip to reservoir edge. The hose is 1000-1100 mm long and manufactured from thick fabric like tarpaulin having circular rubber tension member fixed on the other end. The air-heating system has gas-jet symmetrically arranged on the lower reservoir generatrix at the popliteal space level of patient. The second gas-jet is in the reservoir bottom symmetry center. The gas-jets receive natural gas via hose. Adjustment cock is placed within patient hand reach zone when receiving procedure.

EFFECT: high accuracy in controlling sweat secretion.

1 dwg

Up!